Frontiers Case report: Short-term eculizumab use in atypical HUS

atypical hemolytic uremic syndrome - List of Frontiers' open access articles

Eculizumab discontinuation in children and adults with atypical hemolytic-uremic syndrome: a prospective multicenter study - ScienceDirect

PDF) A systematic review on the efficacy and safety of eculizumab for atypical hemolytic uremic syndrome

PDF) A systematic review on the efficacy and safety of eculizumab for atypical hemolytic uremic syndrome

Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies - ScienceDirect

PDF) The use of eculizumab in gemcitabine induced thrombotic microangiopathy

Atypical Hemolytic Uremic Syndrome: New Challenges in the Complement Blockage Era

PDF) Successful use of eculizumab to treat atypical hemolytic uremic syndrome in patients with inflammatory bowel disease

Optimal management of atypical hemolytic uremic disease: challenges an

Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension